Risk of Progression and Survival in Multiple Myeloma Relapsing After Therapy with IMiDs and Bortezomib: A Multicenter International Myeloma Working Group Study

Promising new drugs are being evaluated for treatment of multiple myeloma (MM), but their impact should be measured against the expected outcome in patients failing current therapies. However, the natural history of relapsed disease in the current era remains unclear. We studied 286 patients with re...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Kumar, Shaji, Lee, Jae Hoon, Lahuerta, Juan J., Morgan, Gareth, Richardson, Paul G., Crowley, John, Haessler, Jeff, Feather, John, Hoering, Antje, Moreau, Philippe, LeLeu, Xavier, Hullin, Cyrille, Klein, Saskia K., Sonneveld, Pieter, Siegel, David, Bladé, Joan, Goldschmidt, Hartmut, Jagannath, Sundar, San Miguel, Jesus, Orlowski, Robert, Palumbo, Antonio, Sezer, Orhan, Durie, Brian G.M.
格式: Artigo
語言:Inglês
出版: 2011
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4109061/
https://ncbi.nlm.nih.gov/pubmed/21799510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2011.196
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍